February 25, 2025
Yale University School of Medicine
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
document
adverse events,COVID-19,immunodeficiency and immunopathological disorders,prior conditions relapse,SARS-CoV-2 spike protein,vaccines